| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 15 | |
| #2 | Australia | 4 | |
| #3 | Brazil | 1 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | Israel | 1 | |
| #8 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Machines | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Unspecified technologies | |
| #4 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Went Gregory T | 20 |
| #2 | Fultz Timothy J | 14 |
| #3 | Mcclure Natalie | 9 |
| #4 | Ganapati Gangadhara | 8 |
| #5 | Shek Efraim | 8 |
| #6 | Vermani Kavita | 8 |
| #7 | Coffee Michael | 8 |
| #8 | Sathyan Gayatri | 8 |
| #9 | Katdare Ashok | 8 |
| #10 | Ghosh Sangita | 7 |
| Publication | Filing date | Title |
|---|---|---|
| US2019328684A1 | Composition and method for treating neurological disease | |
| WO2019040748A1 | Amantadine compositions, preparations thereof, and methods of use | |
| US2019008799A1 | Composition for administering an nmda receptor antagonist to a subject | |
| AU2015343199A1 | Methods of administering amantadine compositions | |
| AU2015202356A1 | Amantadine compositions and methods of use | |
| US2015087721A1 | Methods of administering amantadine |